Gene: MEAF6
Official Full Name: MYST/Esa1 associated factor 6provided by HGNC
Gene Summary: This gene encodes a nuclear protein involved in transcriptional activation. The encoded protein may form a component of several different histone acetyltransferase complexes. There is a pseudogene for this gene on chromosome 2. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO16270 | MEAF6 Knockout cell line (HeLa) | Human | MEAF6 | 1:3~1:6 | Negative | Online Inquiry |
KO16271 | MEAF6 Knockout cell line (HCT 116) | Human | MEAF6 | 1:2~1:4 | Negative | Online Inquiry |
KO16272 | MEAF6 Knockout cell line (HEK293) | Human | MEAF6 | 1:3~1:6 | Negative | Online Inquiry |
KO16273 | MEAF6 Knockout cell line (A549) | Human | MEAF6 | 1:3~1:4 | Negative | Online Inquiry |
MEAF6 Gene Knockout Cell Lines represent a cutting-edge tool designed for the exploration of gene function and validation in various biological contexts. These cell lines are meticulously crafted to lack the MEAF6 gene, a key player in diverse cellular processes such as gene regulation, cell proliferation, and differentiation. By utilizing CRISPR/Cas9 technology, our knockout cell lines provide a precise and reproducible system for studying the effects of MEAF6 absence on cellular behavior and molecular pathways.
The primary mechanism of action revolves around the targeted disruption of the MEAF6 coding sequence, allowing researchers to analyze resultant phenotypes and uncover the gene's role in health and disease. With the ability to model conditions relevant to cancer, metabolic disorders, and other pathologies, MEAF6 knockout cell lines serve as an invaluable resource for investigating gene function dysregulation and its implications for therapeutic interventions.
Scientifically, these cell lines hold immense importance in both research and clinical applications. They facilitate the identification of novel drug targets and biomarkers, as well as aid in the validation of gene therapies. As researchers and clinicians work to unravel complex biological networks, the utility of MEAF6 knockout cell lines becomes evident and critical in driving such innovations.
What sets MEAF6 Gene Knockout Cell Lines apart from conventional alternatives is their robust design, comprehensive characterizations, and high reproducibility, which significantly reduce variability in experimental outcomes. These cell lines come accompanied by detailed usage protocols, enabling swift integration into existing research workflows.
For researchers, clinicians, and therapeutic developers, MEAF6 knockout cell lines are not just a product but a gateway to groundbreaking scientific discovery and innovation. By harnessing the potential of these state-of-the-art tools, our company provides unparalleled support and expertise in advancing biological research and offering solutions that meet the demands of modern science.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.